Injectable contraceptive doubles risk of breast cancer, study shows

(CBS News) An injectable form of birth control doubles breast cancer risk among young women, according to a new study. The study examined younger women, ages 20 to 44, and confirmed a link between depo-medroxyprogesterone acetate (DMPA) – the main ingredient in the contraceptive sold under the brand name Depo-Provera – and breast cancer risk. The contraceptive shot is usually injected into the buttocks or upper arm once every 3 months, or just under the skin once every 12 to 14 weeks….(Source)

Leave a Reply

Your email address will not be published. Required fields are marked *

Solve : *
11 × 10 =